1. Home
  2. Advent

Category: Advent

CalPERS commits another $7.4bn to alts, picks Advent, Thoma Bravo, Silver Lake among big PE investments

Pension giant CalPERS has revealed an enormous $7.4bn of new commitments to alternative investment funds. The post CalPERS commits another $7.4bn to alts, picks Advent, Thoma Bravo, Silver Lake among big PE investments first appeared

Advent pulls in $25bn to close second-largest private equity fund ever raised

Private equity giant Advent International has raised the second-largest private equity fund in history by bringing in $25bn for its new flagship investment vehicle, GPE X. The post Advent pulls in $25bn to close second-largest

Silver Lake bags LACERA commitment for follow up to $20bn Fund VI

The $73.8bn-managing Los Angeles County Employees Retirement Association has picked Silver Lake's latest megafund among a string of new alternative assets commitments. The post Silver Lake bags LACERA commitment for follow up to $20bn Fund

Advent races past target for second tech fund to reach $4bn final close

Global buyout major Advent International has surged to a $4bn final close for its second dedicated tech fundraise, soaring past its initial target. The post Advent races past target for second tech fund to reach

KKR launches buyout valuing Telecom Italia at €33bn, CVC and Advent remain open to options

Global buyout giant KKR has launched a €10.8bn buyout for Italy's largest phone company Telecom Italia, Reuters reported. Together with the net debt of €22.5bn, the deal would value the company at an enterprise value

McAfee to go private again in $14bn PE-led buyout, just a year after IPO

Security software major McAfee is going private again just a year after its IPO thanks to a $14bn buyout deal led by a string of PE firms and institutional investors. The post McAfee to go

Buyout giants eye mammoth $54bn buyout of GlaxoSmithKline consumer unit: report

A string of private equity giants including Blackstone and Carlyle are reportedly circling GlaxoSmithKline’s consumer unit in a deal which could see it valued at up to £40bn. The post Buyout giants eye mammoth $54bn

Advent Life Sciences closes pair of funds totalling $251m

Advent Life Sciences, a transatlantic venture firm focused on life science companies, has closed a pair of new funds totalling $215m.

Advent Life Sciences seals KaNDy sale to industry giant Bayer, deal could be worth over $975m

Europe's Advent Life Sciences has sealed a sale of KaNDy Therapeutics Ltd to industry giant Bayer in a deal which could see it collect in excess of $975m.

Advent, Cinven complete €17.2bn Thyssenkrupp elevator unit buyout signed before Covid-19 pandemic

Global private equity giants Advent and Cinven have closed their €17.2bn takeover of Thyssenkrupp's sought-after elevators business, one of the biggest buyout deals to be completed since full force of the coronavirus pandemic struck.

PE firms eyeing lucrative Italian football broadcast rights forced to wait as clubs mull options – report

Private equity majors eyeing the lucrative broadcasting rights of Italy's top football league have been forced to wait after its clubs asked for more time to assess the proposals, Reuters has reported.

Ex-Advent Benelux head becomes latest high-profile hire at new PE house bd-capital

Advent International's former head of the Benelux is the latest high-profile hire from new private equity house bd-capital.

Cinven emerges as latest Serie A stake bidder after CVC deal valuing it at €10bn falls through – report

Cinven has emerged as the latest private equity player interested in taking a slice of Italy's top football league, Serie A, in the wake of a reported CVC investment valuing the business at €10bn fell

Private equity giants circle Unilever tea business, deal could reach £5bn – report

A string of private equity giants are reportedly circling Unilever's tea business for a buyout which could see it valued at more than £5bn.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.